Stay updated on Tucidinostat & Tislelizumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Tucidinostat & Tislelizumab in NSCLC Clinical Trial page.

Latest updates to the Tucidinostat & Tislelizumab in NSCLC Clinical Trial page
- Check6 days agoChange DetectedRevision v3.4.3 was added to the record history, and the v3.4.2 entry was removed.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Revision: v3.4.2 to the study record history. Removed the government funding notice and the older Revision: v3.4.1.SummaryDifference0.9%

- Check41 days agoChange DetectedA site-wide notice about government funding and operating status was added, and the record history shows a version update from v3.4.0 to v3.4.1.SummaryDifference0.9%

- Check48 days agoChange DetectedThe update adds a glossary toggle, introduces green/red highlights for additions and deletions, and a new Revision: v3.4.0 banner; no changes to study data or results are observed.SummaryDifference1%

- Check84 days agoChange DetectedA new entry Revision: v3.3.3 was added to the record history. The HHS Vulnerability Disclosure and the older Revision: v3.3.2 were removed from the footer.SummaryDifference0.2%

- Check112 days agoChange DetectedA minor revision entry (v3.3.2) was added and v3.2.0 was removed from the revision history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Tucidinostat & Tislelizumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tucidinostat & Tislelizumab in NSCLC Clinical Trial page.